Huizi Wu
Changsha, 410083, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Neural crest-associated gene FOXD1 induces an immunosuppressive microenvironment by regulating myeloid-derived suppressor cells in melanoma.
Journal: Journal for immunotherapy of cancer
Published: March 26, 2025
FOXD1 promotes dedifferentiation and targeted therapy resistance in melanoma by regulating the expression of connective tissue growth factor.
Journal: International journal of cancer
Published: December 23, 2020
Expression of Neural Crest Markers GLDC and ERRFI1 is Correlated with Melanoma Prognosis.
Journal: Cancers
Published: November 21, 2018
Loss of neural crest-associated gene FOXD1 impairs melanoma invasion and migration via RAC1B downregulation.
Journal: International journal of cancer
Published: December 22, 2017
Immunomodulatory Therapies for Renal Cell Carcinoma.
Journal: Protein and peptide letters
Published: July 27, 2017
Drug-Induced Nephrotoxicity: Pathogenic Mechanisms, Biomarkers and Prevention Strategies.
Journal: Current drug metabolism
Published: May 24, 2017
Optimization of Protein and Peptide Drugs Based on the Mechanisms of Kidney Clearance.
Journal: Protein and peptide letters
Published: May 17, 2017
TGF-β induces SOX2 expression in a time-dependent manner in human melanoma cells.
Journal: Pigment cell & melanoma research
Published: August 26, 2015
PEGylated Peptide-Based Imaging Agents for Targeted Molecular Imaging.
Journal: Current protein & peptide science
Published: July 15, 2015
NF1 loss induces senescence during human melanocyte differentiation in an iPSC-based model.
Journal: Pigment cell & melanoma research
Published: January 30, 2015
Showing 1-11 of 11
Last Updated: 09/26/2026